Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 401,505 | 397,505 | -4,000 | $39.67M | $35.80M | 9.10% | -$3.87M |
| Stereotaxis, Inc.(STXS) | 13,680,554 | 13,680,554 | 0 | $27.91M | $31.19M | 7.93% | +$3.28M |
| Revolution Medicines, Inc.(RVMD) | 517,994 | 631,176 | +113,182 | $23.49M | $27.61M | 7.02% | +$4.12M |
| AtriCure, Inc.(ATRC) | 641,673 | 641,673 | 0 | $17.99M | $19.61M | 4.98% | +$1.62M |
| Merus N V | 412,573 | 451,804 | +39,231 | $20.61M | $19.00M | 4.83% | -$1.61M |
| Cytokinetics, Incorporated(CYTK) | 398,100 | 398,100 | 0 | $21.02M | $18.73M | 4.76% | -$2.29M |
| Ascendis Pharma A/SADR(ASND) | 89,572 | 103,355 | +13,783 | $13.37M | $14.23M | 3.62% | +$854.9K |
| Axogen, Inc.(AXGN) | 935,894 | 846,882 | -89,012 | $13.12M | $13.96M | 3.55% | +$835.4K |
| Ishares Nasdaq Biotech IndxETF | 102,500 | 102,500 | 0 | $14.92M | $13.55M | 3.44% | -$1.37M |
| Blueprint Medicines Corp | 121,763 | 149,763 | +28,000 | $11.26M | $13.06M | 3.32% | +$1.80M |
| IDEAYA Biosciences, Inc.(IDYA) | 471,410 | 498,827 | +27,417 | $14.93M | $12.82M | 3.26% | -$2.11M |
| Xenon Pharmaceuticals Inc.(XENE) | 273,739 | 273,739 | 0 | $10.78M | $10.73M | 2.73% | -$46.5K |
| Neurocrine Biosciences, Inc.(NBIX) | 69,615 | 71,615 | +2,000 | $8.02M | $9.78M | 2.48% | +$1.75M |
| Day One Biopharmaceuticals I COM | 750,363 | 731,363 | -19,000 | $10.45M | $9.27M | 2.36% | -$1.19M |
| Biohaven Ltd.(BHVN) | 187,130 | 220,235 | +33,105 | $9.35M | $8.23M | 2.09% | -$1.13M |
| Tandem Diabetes Care, Inc.(TNDM) | 204,208 | 223,208 | +19,000 | $8.66M | $8.04M | 2.04% | -$620.5K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 526,702 | 542,002 | +15,300 | $10.14M | $7.17M | 1.82% | -$2.97M |
| Kalvista Pharmaceuticals Inc | 723,678 | 811,678 | +88,000 | $8.38M | $6.87M | 1.75% | -$1.51M |
| UroGen Pharma Ltd.(URGN) | 458,915 | 492,515 | +33,600 | $5.83M | $5.25M | 1.33% | -$582.9K |
| DexCom, Inc.(DXCM) | 65,552 | 65,552 | 0 | $4.39M | $5.10M | 1.30% | +$703.4K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 667,000 | 667,000 | 0 | $5.07M | $5.02M | 1.27% | -$53.4K |
| Edgewise Therapeutics, Inc.(EWTX) | 227,906 | 187,140 | -40,766 | $6.08M | $5.00M | 1.27% | -$1.09M |
| Ascendis Pharma A/SNOTE 2 250 4 0(ASND) | 0 | 0 | 0 | $4.68M | $4.41M | 1.12% | -$267.5K |
| TELA Bio, Inc.(TELA) | 0 | 1,441,029 | +1,441,029 | $0 | $4.35M | 1.11% | +$4.35M |
| Proqr Therapeutics N VSHS EURO SHS EURO | 905,582 | 1,567,561 | +661,979 | $1.65M | $4.15M | 1.06% | +$2.51M |
| Kura Oncology, Inc.(KURA) | 408,368 | 448,368 | +40,000 | $7.98M | $3.91M | 0.99% | -$4.07M |
| Arcus Biosciences, Inc.(RCUS) | 256,717 | 254,217 | -2,500 | $3.93M | $3.79M | 0.96% | -$139.9K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $3.75M | $3.58M | 0.91% | -$167.9K |
| Alkermes plcSHS(ALKS) | 120,700 | 120,700 | 0 | $3.38M | $3.47M | 0.88% | +$92.9K |
| Insulet Corporation(PODD) | 15,900 | 12,400 | -3,500 | $3.70M | $3.24M | 0.82% | -$463.5K |
| Astria Therapeutics Inc | 254,165 | 299,775 | +45,610 | $2.80M | $2.68M | 0.68% | -$118.4K |
| Immunovant, Inc.(IMVT) | 51,996 | 107,996 | +56,000 | $1.48M | $2.68M | 0.68% | +$1.19M |
| Allogene Therapeutics Inc | 1,050,118 | 1,240,118 | +190,000 | $2.94M | $2.64M | 0.67% | -$298.9K |
| Viking Therapeutics, Inc.(VKTX) | 125,616 | 64,516 | -61,100 | $7.95M | $2.60M | 0.66% | -$5.36M |
| Lexeo Therapeutics, Inc.(LXEO) | 250,583 | 393,083 | +142,500 | $2.27M | $2.59M | 0.66% | +$321.2K |
| Accuray Inc | 1,222,358 | 1,222,358 | 0 | $2.20M | $2.42M | 0.62% | +$220.0K |
| Keros Therapeutics, Inc.(KROS) | 73,754 | 130,316 | +56,562 | $4.28M | $2.06M | 0.52% | -$2.22M |
| Inogen, Inc.(INGN) | 208,790 | 208,790 | 0 | $2.03M | $1.91M | 0.49% | -$110.7K |
| Stoke Therapeutics, Inc.(STOK) | 207,427 | 171,097 | -36,330 | $2.55M | $1.89M | 0.48% | -$662.1K |
| Bicara Therapeutics Inc | 0 | 105,500 | +105,500 | $0 | $1.84M | 0.47% | +$1.84M |
| BrainsWay Ltd.ADS(BWAY) | 251,346 | 193,208 | -58,138 | $2.32M | $1.82M | 0.46% | -$500.5K |
| Mineralys Therapeutics, Inc.(MLYS) | 146,500 | 146,500 | 0 | $1.77M | $1.80M | 0.46% | +$29.3K |
| Immatics N.V.SHS(IMTX) | 145,000 | 245,000 | +100,000 | $1.65M | $1.74M | 0.44% | +$87.5K |
| Alector Inc | 912,928 | 912,928 | 0 | $4.25M | $1.73M | 0.44% | -$2.53M |
| Century Therapeutics, Inc.(IPSC) | 1,704,232 | 1,704,232 | 0 | $2.91M | $1.72M | 0.44% | -$1.19M |
| Bicycle Therapeutics PlcADS | 122,200 | 120,799 | -1,401 | $2.77M | $1.69M | 0.43% | -$1.07M |
| Iteos Therapeutics Inc | 161,584 | 188,347 | +26,763 | $1.65M | $1.45M | 0.37% | -$203.3K |
| Larimar Therapeutics, Inc.(LRMR) | 494,274 | 371,434 | -122,840 | $3.24M | $1.44M | 0.37% | -$1.80M |
| Regulus Therapeutics Inc | 895,200 | 875,200 | -20,000 | $1.41M | $1.38M | 0.35% | -$22.6K |
| Autolus Therapeutics plcADS(AUTL) | 486,667 | 586,667 | +100,000 | $1.77M | $1.38M | 0.35% | -$387.9K |
| Gossamer Bio, Inc.(GOSS) | 1,419,262 | 1,409,262 | -10,000 | $1.40M | $1.27M | 0.32% | -$125.1K |
| 2seventy Bio Inc | 630,029 | 429,252 | -200,777 | $2.97M | $1.26M | 0.32% | -$1.71M |
| Lineage Cell Therapeutics, Inc.(LCTX) | 1,350,708 | 2,511,374 | +1,160,666 | $1.22M | $1.26M | 0.32% | +$39.2K |
| Neurogene Inc.(NGNE) | 7,775 | 51,500 | +43,725 | $326.2K | $1.18M | 0.30% | +$851.1K |
| MediWound Ltd.SHS NEW(MDWD) | 64,479 | 64,479 | 0 | $1.16M | $1.15M | 0.29% | -$16.8K |
| Align Technology Inc | 0 | 5,500 | +5,500 | $0 | $1.15M | 0.29% | +$1.15M |
| BioNTech SEADS(BNTX) | 8,500 | 8,500 | 0 | $1.01M | $968.6K | 0.25% | -$41.0K |
| Structure Therapeutics IncADS | 34,000 | 35,500 | +1,500 | $1.49M | $962.8K | 0.24% | -$529.5K |
| ARS Pharmaceuticals, Inc.(SPRY) | 148,294 | 88,790 | -59,504 | $2.15M | $936.7K | 0.24% | -$1.21M |
| COMPASS Pathways plcADS(CMPS) | 243,210 | 243,210 | 0 | $1.53M | $919.3K | 0.23% | -$612.9K |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 522,500 | +522,500 | $0 | $903.9K | 0.23% | +$903.9K |
| PolyPid Ltd.(PYPD) | 308,497 | 291,273 | -17,224 | $1.06M | $885.5K | 0.23% | -$175.8K |
| Foghorn Therapeutics Inc.(FHTX) | 37,664 | 186,717 | +149,053 | $350.7K | $881.3K | 0.22% | +$530.7K |
| Palvella Therapeutics, Inc.(PVLA) | 0 | 71,452 | +71,452 | $0 | $857.4K | 0.22% | +$857.4K |
| Sutro Biopharma, Inc.(STRO) | 329,579 | 437,079 | +107,500 | $1.14M | $804.2K | 0.20% | -$336.1K |
| Centessa Pharmaceuticals PlcADS | 120,351 | 47,453 | -72,898 | $1.92M | $794.8K | 0.20% | -$1.13M |
| Vir Biotechnology, Inc.(VIR) | 0 | 100,000 | +100,000 | $0 | $734.0K | 0.19% | +$734.0K |
| Compugen Ltd.(CGEN) | 447,202 | 447,202 | 0 | $809.4K | $684.2K | 0.17% | -$125.2K |
| Acrivon Therapeutics Inc | 112,414 | 112,414 | 0 | $786.9K | $676.7K | 0.17% | -$110.2K |
| Sage Therapeutics Inc | 108,200 | 108,200 | 0 | $781.2K | $587.5K | 0.15% | -$193.7K |
| Adicet Bio Inc | 600,000 | 600,000 | 0 | $864.0K | $577.2K | 0.15% | -$286.8K |
| Masimo Corp | 3,000 | 3,000 | 0 | $400.0K | $495.9K | 0.13% | +$95.9K |
| Aquestive Therapeutics Inc | 589,561 | 127,000 | -462,561 | $2.94M | $452.1K | 0.11% | -$2.48M |
| Aprea Therapeutics, Inc.(APRE) | 137,174 | 137,174 | 0 | $377.2K | $451.3K | 0.11% | +$74.1K |
| ADC Therapeutics SASHS(ADCT) | 204,081 | 224,081 | +20,000 | $642.9K | $445.9K | 0.11% | -$196.9K |
| Perspective Therapeutics, Inc.(CATX) | 230,322 | 130,169 | -100,153 | $3.07M | $415.2K | 0.11% | -$2.66M |
| Black Diamond Therapeutics I | 125,000 | 140,000 | +15,000 | $543.8K | $299.6K | 0.08% | -$244.2K |
| Tessera Defense and Homeland Security Inc.(HLSQ) | 401,136 | 401,136 | 0 | $409.2K | $292.9K | 0.07% | -$116.3K |
| Acelyrin Inc | 602,894 | 87,989 | -514,905 | $2.97M | $276.3K | 0.07% | -$2.70M |
| Compass Therapeutics, Inc.(CMPX) | 116,882 | 158,394 | +41,512 | $215.1K | $229.7K | 0.06% | +$14.6K |
| Nevro Corp | 38,000 | 38,000 | 0 | $212.4K | $141.4K | 0.04% | -$71.1K |
| Spero Therapeutics, Inc.(SPRO) | 125,000 | 125,000 | 0 | $167.5K | $128.8K | 0.03% | -$38.8K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 341,064 | 0 | -341,064 | $324.1K | $0 | — | -$324.1K |
| Alto Neuroscience, Inc.(ANRO) | 26,786 | 0 | -26,786 | $306.4K | $0 | — | -$306.4K |
| GRAIL, Inc.(GRAL) | 48,800 | 0 | -48,800 | $671.5K | $0 | — | -$671.5K |
| Karyopharm Therapeutics Inc.(KPTI) | 192,678 | 0 | -192,678 | $159.9K | $0 | — | -$159.9K |
| Neuronetics, Inc.(STIM) | 313,717 | 0 | -313,717 | $238.4K | $0 | — | -$238.4K |
| Nyxoah S ASHS SHS | 108,108 | 0 | -108,108 | $1.03M | $0 | — | -$1.03M |
| Tourmaline Bio Inc | 19,110 | 0 | -19,110 | $491.3K | $0 | — | -$491.3K |
| Verastem, Inc.(VSTM) | 127,700 | 0 | -127,700 | $381.8K | $0 | — | -$381.8K |